Carbon Ion Radiotherapy for Retroperitoneal Sarcoma: A Single-Institution Study
CIRT represents a definitive treatment option for patients with unresectable RPS. In the future, multicenter studies should be conducted to evaluate the effectiveness of CIRT for RPS in larger patient cohorts.
Authors
- Hirotoshi Takiyama (ORCID: https://orcid.org/0000-0001-9994-4666)
- Reiko Imai (ORCID: https://orcid.org/0000-0002-4535-3673)
- Hitoshi Ishikawa (ORCID: https://orcid.org/0000-0002-0046-9787)
- Shigeru Yamada (ORCID: https://orcid.org/0000-0002-4271-0209)
- TSUKASA YONEMOTO
- Hiroaki Ikawa (ORCID: https://orcid.org/0000-0002-1081-1136)
- Nobuhito Araki
Institutions
- Ashiya University (JP)
- National Institutes for Quantum Science and Technology (JP)
- Chiba Cancer Center (JP)
- Chiba Hospital (JP)
Publication Details
- Journal
- Cancers
- Published
- 2025-10-21
- DOI
- https://doi.org/10.3390/cancers17203395
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Dokkyo Medical University